Author:
Baer M R, ,George S L,Sanford B L,Mrózek K,Kolitz J E,Moore J O,Stone R M,Powell B L,Caligiuri M A,Bloomfield C D,Larson R A
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference40 articles.
1. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ et al. (eds). SEER Cancer Statistics Review, 1975–2000. National Cancer Institute: Bethesda, MD, http://seer.cancer.gov/csr/1975_2004/ .
2. Löwenberg B, Zittoun R, Kerkhofs H, Jehn U, Abels J, Debusscher L et al. On the value of intensive remission-induction chemotherapy in elderly patients of 65+years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. J Clin Oncol 1989; 7: 1268–1274.
3. Juliusson G, Antunovic P, Derolf Å, Lehmann S, Möllgård L, Stockelberg D et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood 2009; 113: 4179–4187.
4. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 1994; 331: 896–903.
5. Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE et al. Age and acute myeloid leukemia. Blood 2006; 107: 3481–3485.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献